NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types

NeoGenomics to Participate in Upcoming Investor Conferences

  • NeoLINK Login
  • Investors
  • Contact Us
Search
LogoNeoLINK Login
Menu
  • Home
  • Providers
    Providers
    • Oncology solutions
      • RaDaR ST MRD
      • PanTracer portfolio
      • Lung cancer
      • Breast cancer
      • Colorectal cancer
      • Gastric cancer
      • Gynecologic cancer
      • Hematologic cancers
    • Pathology solutions
      • Test search
      • Lab services
    • Client support & resources
      • EHR Integrations
      • Certifications & licenses
      • Test requisition forms
      • Pathline clients
  • Partners
    Partners
    • Biopharma services
    • RaDaR ST for Pharma Partners
    • Oncology data solutions
    • Regulatory support
  • Patients
  • About NeoGenomics
    About NeoGenomics
    • Who we are
    • Scientific contributions
    • Oncology view
    • Careers
    • Privacy
    • Contact us
  • Billing
    Billing
    • For clinicians
    • For patients
    • Financial assistance
    • Pay your bill online
  • Test Search
  • Investors
Test Search
Skip to main content Skip to section navigation Skip to footer
NeoGenomics, Inc. IR Overview
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report

Press Releases

Investors News & Events Press Releases
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Literature
  • Email Alerts
Feb 5, 2020 7:00 am EST
NeoGenomics Announces Leadership Appointments
Jan 10, 2020 8:40 am EST
NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million
Nov 6, 2019 4:05 pm EST
NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference
Oct 29, 2019 7:00 am EDT
NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter
Oct 1, 2019 4:05 pm EDT
NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019
Sep 25, 2019 4:05 pm EDT
NeoGenomics To Present At 2019 Cantor Global Healthcare Conference
Sep 3, 2019 4:15 pm EDT
NeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences
Aug 8, 2019 8:45 am EDT
NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance
Jul 31, 2019 7:00 am EDT
NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore
Jul 30, 2019 7:00 am EDT
NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • …
  • Page 32
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • rss_feedRSS News Feed
  • account_treeSitemap
©2026 NeoGenomics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences